CARVEDILOL for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 20 adverse event reports in the FDA FAERS database where CARVEDILOL was used for Psoriasis.
Most Reported Side Effects for CARVEDILOL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hypotension | 1,822 | 13.3% | 109 | 1,111 |
| Dyspnoea | 1,143 | 8.4% | 35 | 587 |
| Dizziness | 1,138 | 8.3% | 23 | 462 |
| Drug ineffective | 1,102 | 8.1% | 57 | 434 |
| Fatigue | 1,020 | 7.5% | 26 | 345 |
| Completed suicide | 1,019 | 7.5% | 1,019 | 358 |
| Bradycardia | 861 | 6.3% | 71 | 661 |
| Toxicity to various agents | 690 | 5.0% | 384 | 415 |
| Cardiac failure | 636 | 4.7% | 82 | 482 |
| Asthenia | 562 | 4.1% | 22 | 276 |
| Acute kidney injury | 518 | 3.8% | 87 | 394 |
| Drug interaction | 508 | 3.7% | 13 | 274 |
| Hypertension | 504 | 3.7% | 11 | 218 |
| Syncope | 456 | 3.3% | 17 | 307 |
| Headache | 453 | 3.3% | 11 | 175 |
Other Indications for CARVEDILOL
Product used for unknown indication (6,751)
Hypertension (2,080)
Cardiac failure (596)
Cardiac disorder (284)
Cardiac failure congestive (217)
Atrial fibrillation (199)
Cardiac failure chronic (126)
Blood pressure abnormal (112)
Suicide attempt (109)
Blood pressure measurement (101)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)